Devices & Diagnostics

Syncro Medical Innovations adds funding to complete feeding tube

The money will help help bring its Syncro Blue Tube device to market by the end of this year.

YOUNGSTOWN, Ohio — Feeding-tube maker Syncro Medical Innovations has raised $500,000 through debt, according to a filing with the Securities and Exchange Commission.

The 4-year-old company told VentureWire the money will help help bring its Syncro Blue Tube (also known as its Gabriel Feeding Tube) to market by the end of this year. Its biggest investor, Boston’s Norwich Ventures, participated in the fund-raise.

The Syncro Blue Tube is an intestinal feeding tube guided using an external magnet past the stomach and to a section of the small intestine called the duodenum. This is a bedside procedure that hopes to eliminate the need for fluoroscopy, endoscopy or medications and cut the number of X-rays.

The company doesn’t have a Web site. But some of its older demonstration videos can be found on YouTube. There’s both a video demonstration and a patient demonstration.